Jenny Sadler Gallagher

No ORCID on file · 15 papers in corpus · active 2015-2025

Study types

  • article 14
  • other 1

Condition tags

  • endometriosis 15
  • mesh:D004715 6
  • mesh:D017699 2
  • chronic_pelvic_pain 2
  • mesh:D004412 1
  • mesh:D004414 1
  • dyspareunia 1
  • dysmenorrhea 1
article 2025
14. Quantitative Sensory Testing in Females with Endometriosis and Chronic Pelvic Pain
·doi:10.1016/j.jpag.2025.01.027
article 2024
2. Depression in Adolescent and Adult Women with Endometriosis
·doi:10.1016/j.jpag.2024.01.147
article 2024
97. Pain Interference in Adolescents and Adults with Chronic Pelvic Pain Due to Endometriosis
·doi:10.1016/j.jpag.2024.01.104
other 2022
Cohort profile: The Endometriosis pain QUality aftEr Surgical Treatment (EndoQUEST) Study
PloS one ·doi:10.1371/journal.pone.0269858

Endometriosis affects reproductive-aged females and varies considerably in terms of symptom presentation, morphologic features, and treatment response. Most studies investigating symptom recurrence after an endometriosis-related surgery hav…

article 2022
Trends in pelvic pain symptoms over 2 years of follow-up among adolescents and young adults with and without endometriosis
Pain ·doi:10.1097/j.pain.0000000000002747

ABSTRACT: We described trends in pelvic pain characteristics over 2 years of follow-up among adolescents and adults with and without endometriosis participating in the longitudinal observational cohort of the Women's Health Study: From Adol…

article 2021
Nonhormonal therapy for endometriosis: a randomized, placebo-controlled, pilot study of cabergoline versus norethindrone acetate
F&S reports ·doi:10.1016/j.xfre.2021.07.003

OBJECTIVE: To estimate the efficacy and safety of a novel nonhormonal therapeutic agent, cabergoline, compared with that of the standard clinical therapy, norethindrone acetate (NETA), for the treatment of endometriosis-associated pain in y…

article 2018
Long-Term Effects of Gonadotropin-Releasing Hormone Agonist and Add-Back in Adolescent Endometriosis
·doi:10.1016/j.jpag.2018.02.074
article 2018
Long-Term Effects of Gonadotropin-Releasing Hormone Agonists and Add-Back in Adolescent Endometriosis
Journal of pediatric and adolescent gynecology ·doi:10.1016/j.jpag.2018.03.004
article 2018
The Impact of Endometriosis on Quality of Life in Adolescents
The Journal of adolescent health : official publication of the Society for Adolescent Medicine ·doi:10.1016/j.jadohealth.2018.06.027
article 2016
Factors Associated with Quality of Life in Adolescents with Endometriosis
·doi:10.1016/j.jpag.2016.01.099
article 2016
The Effects of Gonadotropin-Releasing Hormone Agonist Combined with Add-Back Therapy on Quality of Life for Adolescents with Endometriosis: A Randomized Controlled Trial
Journal of pediatric and adolescent gynecology ·doi:10.1016/j.jpag.2016.02.008
article 2015
45. The Effect of Hormonal Add-back Therapy in Adolescents Treated With a Gonadotropin Releasing Hormone (GnRH) Agonist for Endometriosis: A Randomized Trial
·doi:10.1016/j.jadohealth.2014.10.049
article 2015
Hormonal Add-Back Therapy for Females Treated With Gonadotropin-Releasing Hormone Agonist for Endometriosis
Obstetrics and gynecology ·doi:10.1097/aog.0000000000000964

OBJECTIVE: To assess whether add-back therapy with norethindrone acetate or norethindrone acetate plus conjugated equine estrogens is superior to maintain bone health in adolescents and young women using gonadotropin-releasing hormone agoni…

article 2015
Hormonal Add-Back Therapy for Females Treated With Gonadotropin-Releasing Hormone Agonist for Endometriosis
·doi:10.1097/ogx.0000000000000249

Endometriosis often begins during adolescence. Appropriate management includes prompt initiation of therapy and long-term maintenance therapy. Gonadotropin-releasing hormone (GnRH) agonists are commonly used second-line therapy for patients…

article 2015
The Effect of Hormonal Add-Back Therapy in Adolescents Treated With a Gonadotropin Releasing Hormone (GnRH) Agonist for Endometriosis: A Randomized Trial
·doi:10.1016/j.jpag.2015.02.008